Iress Historical Cash Flow

IRE Stock

9.29 0.10 1.06%

Analysis of Iress cash flow over time is an excellent tool to project Iress future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 136.1 M or Capital Expenditures of 11.5 M as it is a great indicator of Iress ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Iress latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Iress is a good buy for the upcoming year.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iress. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Iress Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Iress balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Iress's non-liquid assets can be easily converted into cash.

Iress Cash Flow Chart

At this time, Iress' Free Cash Flow is comparatively stable compared to the past year. Other Non Cash Items is likely to gain to about 136.1 M in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (16.2 M).

Free Cash Flow Begin Period Cash Flow Other Cashflows From Financing Activities Capital Expenditures Investments Change To Netincome

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Iress to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Iress operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Most accounts from Iress' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Iress current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iress. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Iress cash flow statement Correlations

	Change In Cash	Free Cash Flow	Begin Period Cash Flow	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Dividends Paid	Sale Purchase Of Stock	Depreciation	Change To Account Receivables	Investments	Net Borrowings	Stock Based Compensation	Change In Working Capital	Change To Operating Activities	Change To Netincome	Change To Liabilities	Change To Inventory	Issuance Of Capital Stock
Change In Cash		0.4	-0.56	-0.3	-0.3	0.27	0.25	0.41	-0.15	-0.03	0.2	-0.18	-0.2	0.21	-0.31	-0.14	-0.21	-0.21	-0.12	0.14
Free Cash Flow	0.4		-0.05	-0.26	-0.13	0.41	0.31	0.27	0.27	0.19	0.14	-0.66	-0.81	0.41	-0.32	-0.27	-0.36	-0.25	0.21	0.06
Begin Period Cash Flow	-0.56	-0.05		-0.08	0.48	0.01	0.63	-0.11	-0.09	0.17	-0.01	-0.06	0.22	-0.01	0.06	0.01	-0.02	-0.03	-0.16	-0.22
Other Non Cash Items	-0.3	-0.26	-0.08		-0.34	-0.79	-0.25	-0.72	0.07	-0.01	-0.04	0.34	0.02	-0.15	0.74	0.0	0.17	0.58	0.09	-0.2
Capital Expenditures	-0.3	-0.13	0.48	-0.34		0.12	0.27	0.24	-0.2	0.4	0.07	0.14	0.03	0.28	-0.27	-0.14	-0.18	0.15	-0.2	-0.23
Net Income	0.27	0.41	0.01	-0.79	0.12		0.11	0.27	0.38	-0.47	-0.05	-0.55	-0.23	-0.27	-0.38	0.23	-0.11	-0.73	0.13	0.56
End Period Cash Flow	0.25	0.31	0.63	-0.25	0.27	0.11		0.24	-0.32	0.29	0.19	-0.16	0.07	0.23	-0.19	-0.18	-0.25	-0.12	-0.33	-0.24
Dividends Paid	0.41	0.27	-0.11	-0.72	0.24	0.27	0.24		-0.43	0.51	0.06	-0.17	-0.11	0.68	-0.88	-0.37	-0.29	-0.16	-0.21	-0.33
Sale Purchase Of Stock	-0.15	0.27	-0.09	0.07	-0.2	0.38	-0.32	-0.43		-0.56	0.06	-0.3	-0.36	-0.44	0.35	0.61	-0.29	-0.23	0.04	0.57
Depreciation	-0.03	0.19	0.17	-0.01	0.4	-0.47	0.29	0.51	-0.56		0.07	0.22	-0.16	0.87	-0.48	-0.6	-0.32	0.45	-0.18	-0.81
Change To Account Receivables	0.2	0.14	-0.01	-0.04	0.07	-0.05	0.19	0.06	0.06	0.07		-0.46	-0.24	0.18	0.26	-0.08	-0.26	-0.09	-0.17	0.23
Investments	-0.18	-0.66	-0.06	0.34	0.14	-0.55	-0.16	-0.17	-0.3	0.22	-0.46		0.67	-0.1	0.05	0.24	0.06	0.49	-0.38	-0.38
Net Borrowings	-0.2	-0.81	0.22	0.02	0.03	-0.23	0.07	-0.11	-0.36	-0.16	-0.24	0.67		-0.42	0.1	0.34	0.29	0.08	-0.35	-0.09
Stock Based Compensation	0.21	0.41	-0.01	-0.15	0.28	-0.27	0.23	0.68	-0.44	0.87	0.18	-0.1	-0.42		-0.56	-0.65	-0.3	0.33	-0.09	-0.65
Change In Working Capital	-0.31	-0.32	0.06	0.74	-0.27	-0.38	-0.19	-0.88	0.35	-0.48	0.26	0.05	0.1	-0.56		0.29	0.3	0.32	0.09	0.31
Change To Operating Activities	-0.14	-0.27	0.01	0.0	-0.14	0.23	-0.18	-0.37	0.61	-0.6	-0.08	0.24	0.34	-0.65	0.29		-0.15	-0.22	-0.51	0.59
Change To Netincome	-0.21	-0.36	-0.02	0.17	-0.18	-0.11	-0.25	-0.29	-0.29	-0.32	-0.26	0.06	0.29	-0.3	0.3	-0.15		0.17	0.56	0.22
Change To Liabilities	-0.21	-0.25	-0.03	0.58	0.15	-0.73	-0.12	-0.16	-0.23	0.45	-0.09	0.49	0.08	0.33	0.32	-0.22	0.17		-0.13	-0.56
Change To Inventory	-0.12	0.21	-0.16	0.09	-0.2	0.13	-0.33	-0.21	0.04	-0.18	-0.17	-0.38	-0.35	-0.09	0.09	-0.51	0.56	-0.13		0.14
Issuance Of Capital Stock	0.14	0.06	-0.22	-0.2	-0.23	0.56	-0.24	-0.33	0.57	-0.81	0.23	-0.38	-0.09	-0.65	0.31	0.59	0.22	-0.56	0.14

Click cells to compare fundamentals

Iress Account Relationship Matchups

Iress cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change In Cash	3.2M	29.8M	1.3M	(1.0M)	(19.5M)	(18.5M)
Free Cash Flow	91.7M	101.4M	77.1M	65.7M	44.2M	51.2M
Begin Period Cash Flow	30.2M	33.4M	63.1M	64.4M	63.4M	40.5M
Other Cashflows From Financing Activities	111.8M	132.3M	(14.0M)	354.6M	(17.1M)	(16.2M)
Other Non Cash Items	(102.4M)	(98.4M)	(120.8M)	(93.3M)	129.6M	136.1M
Capital Expenditures	13.0M	23.5M	24.1M	27.6M	19.4M	11.5M
Net Income	65.1M	59.1M	73.8M	52.7M	(137.5M)	(130.6M)
End Period Cash Flow	33.4M	63.1M	64.4M	63.4M	43.9M	42.3M
Dividends Paid	75.9M	80.7M	85.7M	86.9M	(55.4M)	(52.7M)
Total Cash From Operating Activities	104.7M	124.9M	101.2M	93.3M	63.7M	65.1M
Total Cash From Financing Activities	(71.1M)	43.8M	(64.4M)	(77.9M)	(108.3M)	(102.8M)
Sale Purchase Of Stock	448K	(4.1M)	(68.2M)	(74.8M)	(67.3M)	(64.0M)
Depreciation	37.2M	39.4M	47.0M	40.7M	51.0M	53.6M
Change To Account Receivables	(9.5M)	24.3M	(5.1M)	(10.2M)	138K	144.9K
Other Cashflows From Investing Activities	(20.5M)	(115.8M)	(10.4M)	(4.3M)	(3.9M)	(4.1M)
Investments	(33.5M)	(139.3M)	(34.6M)	(32.0M)	25.8M	27.1M
Net Borrowings	6.4M	(47.0M)	89.1M	83.9M	75.5M	79.3M
Stock Based Compensation	17.7M	21.0M	17.4M	18.7M	20.5M	15.3M
Change In Working Capital	(44.4M)	(18.7M)	(48.7M)	(29.0M)	(397K)	(416.9K)
Total Cashflows From Investing Activities	(33.5M)	(139.3M)	(34.6M)	(32.0M)	(36.7M)	(38.6M)
Change To Operating Activities	(841K)	2.5M	(917K)	(14.1M)	(12.7M)	(12.1M)
Change To Netincome	14.8M	3.4M	(6.2M)	20.7M	18.7M	10.0M
Change To Liabilities	(4.8M)	(2.3M)	(9.0M)	8.0M	9.2M	9.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Iress Stock Analysis

When running Iress' price analysis, check to measure Iress' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iress is operating at the current time. Most of Iress' value examination focuses on studying past and present price action to predict the probability of Iress' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iress' price. Additionally, you may evaluate how the addition of Iress to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC